📷 Image: Wikimedia Commons / Original: Vyacheslav Argenberg
Derivative work:
Business
SEC Approves GOA Therapeutics' $300 Million IPO, Set to Launch Oct 15
✍️ The Manila Times
🗓 14 Oct 2026, 06:17 AM
👁 20
The U.S. Securities and Exchange Commission has qualified GOA Therapeutics’ public offering, allowing the company to sell up to $300 million in shares. The IPO is scheduled to begin trading on October 15.
The U.S. Securities and Exchange Commission (SEC) has officially qualified GOA Therapeutics’ public offering, permitting the company to offer up to $300 million in new shares. The qualification means the company can now proceed with the initial public offering, which is slated to begin trading on October 15. The move follows the company’s filing of a registration statement and compliance with SEC disclosure requirements.
GOA Therapeutics will use the proceeds from the offering to support its growth initiatives and research pipeline. Investors will have the opportunity to purchase shares in the company through the primary market, with the offering price and allocation details to be announced shortly.
The SEC’s approval is a key milestone for the company, signaling that its financial statements and corporate governance meet regulatory standards. The IPO will provide a liquidity event for existing shareholders and broaden the company’s investor base.
GOA Therapeutics will use the proceeds from the offering to support its growth initiatives and research pipeline. Investors will have the opportunity to purchase shares in the company through the primary market, with the offering price and allocation details to be announced shortly.
The SEC’s approval is a key milestone for the company, signaling that its financial statements and corporate governance meet regulatory standards. The IPO will provide a liquidity event for existing shareholders and broaden the company’s investor base.